Hobart Private Capital, LLC Johnson & Johnson Transaction History

Hobart Private Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 11, 2024	SELL	$137.11 - $157.38 $7,129 - $8,183	-52 Reduced 2.8%	1,803 $284 Million
Q3 2020 Mar 11, 2024	SELL	$140.38 - $153.83 $23,162 - $25,381	-165 Reduced 8.17%	1,855 $276 Million
Q2 2020 Mar 11, 2024	BUY	$128.81 - $155.51 $34,521 - $41,676	268 Added 15.3%	2,020 $284 Million
Q4 2019 Mar 11, 2024	BUY	$127.5 - $146.44 $223,380 - $256,562	1,752 New	1,752 $256 Million
Q1 2019 Mar 11, 2024	SELL	$125.72 - $139.79 $261,874 - $291,182	-2,083 Reduced 55.77%	1,652 $231 Million
Q4 2018 Mar 11, 2024	BUY	$122.84 - $147.84 $37,466 - $45,091	305 Added 8.89%	3,735 $482 Million
Q3 2018 Mar 11, 2024	BUY	$121.58 - $142.88 $117,324 - $137,879	965 Added 39.15%	3,430 $474 Million
Q2 2018 Mar 11, 2024	BUY	$119.4 - $131.76 $48,237 - $53,231	404 Added 19.6%	2,465 $299 Million
Q1 2018 Mar 11, 2024	BUY	$125.1 - $148.14 $257,831 - $305,316	2,061 New	2,061 $264 Million
Q4 2017 Mar 11, 2024	BUY	$131.22 - $143.62 $301,806 - $330,326	2,300	2,300 $321 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hobart Private Capital, LLC with notifications on news.